2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol
C22H28N4O2S — CID 130370915
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol
2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol (PubChem CID 130370915) has the molecular formula C22H28N4O2S and a molecular weight of 412.56 g/mol. Its IUPAC name is 2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol.
Molecular Properties
| Compound Name | 2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol |
|---|---|
| PubChem CID | 130370915 |
| Molecular Formula | C22H28N4O2S |
| Molecular Weight | 412.56 g/mol |
| Exact Mass | 412.19 |
| IUPAC Name | 2-[2-[1-methyl-5-(2-methylphenyl)pyrazol-4-yl]-1,3-thiazol-4-yl]-1-(oxan-4-ylmethylamino)ethanol |
| SMILES | Cc1ccccc1-c1c(-c2nc(CC(O)NCC3CCOCC3)cs2)cnn1C |
| InChI | InChI=1S/C22H28N4O2S/c1-15-5-3-4-6-18(15)21-19(13-24-26(21)2)22-25-17(14-29-22)11-20(27)23-12-16-7-9-28-10-8-16/h3-6,13-14,16,20,23,27H,7-12H2,1-2H3 |
| InChIKey | UFXKMSIRLVCJCD-UHFFFAOYSA-N |
| XLogP | 3.40 |
| TPSA | 72.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.56 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130370915 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.